Swedish researchers from the Lund University have developed a new blood test that can detect early stages of pancreatic cancer.

The researchers explained in their study published in the journal of Clinical Oncology, that their new test can detect pancreatic cancer with 96% accuracy at stage I and II, while there is still the possibility of successful surgical intervention."

Currently, this type of cancer, which represents 3% of cancer cases, is hard to be diagnosed.

Scientists expect the pancreatic cancer to become the second most dangerous cancer in the world by 2030.

Carl Borrebaeck, professor at the department of Immunotechnology at Lund University said the team used samples from patients in both Denmark and the US.

The test is based on monitoring a few dozens of the hundreds signs detected during the immune system's operations to resist germs, diseases or malignant tumors.